Masonic Cancer Center

A Comprehensive Cancer Center designated by the National Cancer Institute

Find a Clinical Trial

Quick Search (by title or disease)

Go to Advanced Search for more options.

Clinical Trials Help
Contact our Cancer Information Line nurse with your questions about open or upcoming clinical trials, second opinions, or patient referrals. • 612-624-2620 • 1-888-226-2376

Gynecologic cancers Clinical Trials

Protocol Number Title
MT2005-21 Autologous Peripheral Blood Stem Cell Transplant for Germ Cell Tumors
WCC 60 Biomarker with Biological Function in Ovarian Carcinoma/Diagnostic Markers for Ovarian Cancer: Detection of Novel Cell Adhesion Proteins in Patients' Specimens
Minnesota Community Networks Center for Eliminating Cancer Disparities: Cervical Cancer Screening Project Part C Quantitative
Mobile Phone Text Messaging Intervention for Cervical Cancer Screening
Molecular Epidemiology of Pediatric Germ Cell Tumors
"Chemotherapy Brain" after Treatment for Ovarian Cancer - Does it Exist?
Proteomic Detection of Ovarian Cancer Biomarkers in Routine Pap Tests; Detection of ovarian cancer biomarkers in routine Pap tests by mass-spectrometry based proteomic techniques; Identification and validation of ovarian cancer protein biomarkers in routine Pap tests; Proteomic and metabolic detection of ovarian cancer biomarkers in routine Pap tests; Proteomic analysis of Pap tests for the detection of ovarian cancer biomarkers; Verification of ovarian cancer protein biomarkers in routine Pap tests by mass spectrometry analysis
GOG 274 A phase III trial of adjuvant chemotherapy following chemoradiation as primary treatment for locally advanced cervical cancer compared to chemoradiation alone: THE OUTBACK TRIAL (ANZGOG 0902)
GOG-0244 The Lymphedema and Gynecologic Cancer (LEG) Study: Incidence, Risk Factors and Impact in Newly Diagnosed Patients
Implementation of a Rapid Recovery Program in Gynecologic Oncology Surgery: A Pilot Study
MT2013-11: Indoleamine-2,3-dioxygenase (IDO) Inhibition with INCB024360 and Intraperitoneal Delivery of Allogeneic Natural Killer Cells for Women with Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancer
ACRIN 6671/GOC 0233: Utility of Preoperative FDG-PET/CT Scanning to Detect Retroperitoneal Lymph Node Metastasis in Patients with Locoregionally Advanced Carcinoma of the Cervix and High Risk Endometrial Cancer.
Making End of Life Decision in Ovarian Cancer: When to Enter Hospice? A Prototype Interactive Computer Program for Patients and Providers
Patients Goals for Undergoing Surgery by a Gynecologic Oncologist
GROningen INternational Study on Sentinel nodes in Vulvar cancer (GROINSS-V) -An Observational Study GOG 270
A Pilot Study of the Immunological Effects of Neo-Adjuvant INCB024360 in Patients with Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Carcinoma
A Phase 3 Randomized Double-blind Trial of Maintenance with Niraparib versus Placebo in Patients with Platinum Sensitive Ovarian Cancer
Website-Based Hereditary Cancer Risk Assessment for Ovarian Cancer Patients
Minnesota Internet Self-collection Screening (MISS) Study Grant Title: A Survey to Determine Screening and Human Papillomavirus Vaccination Uptake between Minnesota Counties with Varying Rates of Cervical Cancer
Sexual Dysfunction and Quality of Life after Treatment for Gynecologic Cancer.

20 trials displayed

  • ©2013 Regents of the University of Minnesota. All rights reserved.
  • The University of Minnesota is an equal opportunity educator and employer
  • Last modified on